Subconjunctival triamcinolone acetate versus topical steroid for control of inflammation after phacoemulsification surgery - A randomized control trial.
Indian J OphthalmolAug 24, 2026 (epub)
Clinical ResearchOphthalmology
Harshita Moond, Neha K Sethi, Gagandeep Kaur et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial compared the efficacy of subconjunctival triamcinolone acetate versus topical prednisolone for managing postoperative inflammation in 100 eyes after phacoemulsification surgery. The study found no significant differences in anterior chamber cells, flare, or mean intraocular pressure between the two groups. However, subconjunctival hemorrhage was significantly more common in the triamcinolone group (P 0.001).
Key findings
- No significant difference in anterior chamber cells, flare, or mean intraocular pressure between groups.
- Subconjunctival hemorrhage occurred significantly more in Group A (P 0.001) on days 1 and 7.
- All patients achieved good postoperative visual acuity gains.
Why it matters
Understanding the comparative effectiveness of different steroid administration routes can help clinicians optimize postoperative care and manage inflammation effectively after cataract surgery.